| Name | 3-oxo-5β-cholanic acid |
|---|---|
| Synonyms |
3-ketolithocholicacid
3-oxocholanic acid 3-oxocholan-24-oic acid 3-oxo-5-beta-cholan-24-oicacid 5β-Cholanic acid-3-one 3-Oxo-5β-cholanoic Acid (R)-4-((5R,8R,9S,10S,13R,14S,17R)-10,13-Dimethyl-3-oxohexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid 3-Keto-5beta-cholanic acid (5-beta)-cholan-24-oicaci 3-Oxo-5β-cholan-24-oic acid 3-Keto-5β-cholanic acid 3-oxocholanicacid 3-oxo-5-beta-cholan-24-oicaci Ursodeoxycholic acid impurity 60 DEHYDROLITHOCHOLIC ACID 3-Oxo-5β-cholanoic acid, 10 mM in DMSO 5-B-CHOLANIC ACID-3-ONE 3-Oxo-5β-cholanic acid Cholan-24-oic acid, 3-oxo-, (5β) 3-Keto-5β-cholanic acid, Dehydrolithocholic acid 3-KETOCHOLANIC ACID 5BETA-CHOLANIC ACID-3-ONE 3-Oxo-5beta-cholanoic Acid cell,factor,R-related orphan rector,3 Oxo 5β cholanoic acid,TH17,RORγt,differentiation,acid,bile,Inhibitor,responses,transcription,inhibit,ROR,3Oxo5βcholanoic acid,immune,3-oxoLCA 3-oxolithocholicacid 3-oxo-5beta-cholanic acid |
| Description | 3-Oxo-5β-cholanoic acid (Dehydrolithocholic acid), a bile acid metabolite, inhibits the diferentiation of TH17 cells by directly binding to the key transcription factor RORγt (Kd=1.13 μM)[1]. |
|---|---|
| Related Catalog | |
| In Vitro | Treatment with 3-Oxo-5β-cholanoic acid significantly reduced the activity of the RORγt reporter. These data suggest that 3-Oxo-5β-cholanoic acid probably inhibits TH17 cell differentiation by physically interacting with RORγt, and inhibiting its transcriptional activity[1]. |
| In Vivo | 3-Oxo-5β-cholanoic acid (Dehydrolithocholic acid) (0.3% (w/w); p.o.; for 1 week) significantly reduces the percentage of ileal TH17 cells[1]. Animal Model: B6 Jax mice (with a faecal slurry containing SFB)[1] Dosage: 0.3% (w/w) Administration: Gavaged; for 1 week Result: Significantly reduced the percentage of ileal TH17 cells. |
| References |
| Density | 1.069 g/cm3 |
|---|---|
| Boiling Point | 509.3ºC |
| Molecular Formula | C24H38O3 |
| Molecular Weight | 374.55700 |
| Flash Point | 275.9ºC |
| Exact Mass | 374.28200 |
| PSA | 54.37000 |
| LogP | 5.71530 |
| Vapour Pressure | 0mmHg at 25°C |
| Index of Refraction | 1.52 |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATAMUTATION DATA
|
|
~94%
1553-56-6 |
| Literature: Nahar, Lutfun; Turner, Alan B. Journal of Chemical Research, 2004 , # 5 p. 329 - 332 |
|
~%
1553-56-6 |
| Literature: Faarup, Peter Patent: US2002/183531 A1, 2002 ; |
|
~%
1553-56-6
Detail
|
| Literature: Yang, Jerry; Gabriele, Bartolo; Belvedere, Sandro; Huang, Ying; Breslow, Ronald The Journal of organic chemistry, 2002 , vol. 67, # 15 p. 5057 - 5067 |
|
~%
1553-56-6 |
| Literature: Kagan; Jacques Bulletin de la Societe Chimique de France, 1957 , p. 699,703 |
|
~%
1553-56-6 |
| Literature: Kagan; Jacques Bulletin de la Societe Chimique de France, 1957 , p. 699,703 |
|
~%
1553-56-6 |
| Literature: Kagan; Jacques Bulletin de la Societe Chimique de France, 1957 , p. 699,703 |
|
~%
1553-56-6 |
| Literature: Kagan; Jacques Bulletin de la Societe Chimique de France, 1957 , p. 699,703 |
|
~%
1553-56-6 |
| Literature: Kagan; Jacques Bulletin de la Societe Chimique de France, 1957 , p. 699,703 |
|
~%
1553-56-6 |
| Literature: Kagan; Jacques Bulletin de la Societe Chimique de France, 1957 , p. 699,703 |
| Precursor 6 | |
|---|---|
| DownStream 1 | |